Fundraising Fox

Cytotronics

Boston, US · Founded 2020 · Delaware corporation · 3 known investors

cytotronics.com ↗

Cytotronics develops Pixel, a semiconductor-to-live-cell interface platform that enables real-time monitoring of multiple cellular properties for drug discovery and cell biology research. The platform is used by scientists across therapeutic areas including vascular biology, stem cell differentiation, and disease modeling.

Deep TechMedical Devicesin /cytotronics

Founders & leadership

JAJeffrey Abbott
Jeffrey AbbottExecutive Officer, Director
WW
Wenxuan WuExecutive Officer, Director
SRSameer Rohatgi
Sameer RohatgiDirector
JAJenna Abelli
Jenna AbelliDirector
DKDouglas Kahn
Douglas KahnDirector

Investors · 3

Bantam GroupWestwood
Draper AssociatesSan Mateo · $500K – $5M
BoxOne VenturesreportedMontréal · $500K

Reported raises · per SEC filings

Form D private placements
▶$13.5MraisedOct 2024 · 10 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sameer RohatgiDirector
  • Jeffrey AbbottExecutive Officer, Director
  • Douglas KahnDirector
  • Wenxuan WuExecutive Officer, Director
  • Jenna AbelliDirector
Offering amount
$13.5M
Amount sold
$13.5M
First sale
Mar 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.